Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
Shockwave Medical (NASDAQ: SWAV) will announce its third quarter 2022 financial results on November 7, 2022, after market close. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET the same day. Investors can access the live and archived webcast through the company’s Investors section on its website. Shockwave Medical specializes in Intravascular Lithotripsy (IVL), a novel treatment for calcified cardiovascular disease, aiming to set a new standard in interventional care.
- Scheduled release of Q3 2022 financial results indicates transparency.
- Focus on Intravascular Lithotripsy (IVL) positions the company in a growing market for cardiovascular treatment.
- None.
SANTA CLARA, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, will report financial results for the third quarter 2022 after market close on Monday, November 7, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Interested parties may access live and archived webcasts of these events on the "Investors" section of the company’s website at https://ir.shockwavemedical.com. Investors interested in listening to the third quarter 2022 Shockwave Medical earnings conference call on Monday November 7, 2022, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time may do so by dialing 877-704-4453 for domestic callers or 201-389-0920 for international callers, using conference ID:13733213.
About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.
Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com
Investor Contact:
Debbie Kaster
investors@shockwavemedical.com
FAQ
When will Shockwave Medical report its Q3 2022 financial results?
What time is the conference call for Shockwave Medical's Q3 2022 earnings?
How can I access the webcast of Shockwave Medical's earnings call?
What is the stock symbol for Shockwave Medical?
